Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iloprost for Pulmonary Oxygenation in COPD During One-lung Ventilation
NCT02490657Completed
- Sponsor
- Yonsei University
- Start
- Jul 2015
- Primary completion
- May 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of iloprost in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Yonsei University. Primary endpoint: PaO2 /FiO2 ratio during one-lung ventilation. Started Jul 2015; status: completed.
02
Drugs
iloprost
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02490657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02490657.